R&D Start-Ups Urged To Retain Production Control When Doing Deals
Executive Summary
Start-up companies can protect themselves when doing development and marketing deals with big pharma by holding on to manufacturing rights, Vanguard Medica CEO Robert Mansfield suggested at an Ernst & Young/Atlas Venture conference in Amsterdam on April 19.